RE:RE:RE:Reverse split...The reverse split won't change the value of the company, allit will do in the short run is reduce the share float and give the remaining shares on the market a higher price. The company has enough money right now so I do not for see any need to go to the market for additional funds. If the stock hasn't moved at all once those 14 million warrants are exercised or not (worst case) then I see a problem for cash.
If they are all exercised that is another 800K in the bank, but until we get closer to FDA approval and more data there is really no reason why there would be any major movement up or down.
My opinion of course